<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Mathematical Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4E785017-F899-42F8-A33D-D83CF3656B35"><gtr:id>4E785017-F899-42F8-A33D-D83CF3656B35</gtr:id><gtr:name>Unilever Corporate Research</gtr:name><gtr:address><gtr:line1>Unilever House</gtr:line1><gtr:postCode>KT22 7GR</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8CFC91FA-535C-4721-87D4-3589AFFBA5C9"><gtr:id>8CFC91FA-535C-4721-87D4-3589AFFBA5C9</gtr:id><gtr:name>Dudley Group of Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Dudley Group of Hospitals NHS Trust</gtr:line1><gtr:line2>Russells Hall Hospital</gtr:line2><gtr:postCode>DY1 2HQ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D3623E02-9971-4627-A724-80171F94850B"><gtr:id>D3623E02-9971-4627-A724-80171F94850B</gtr:id><gtr:name>Clatterbridge Cen for Oncology NHS Trust</gtr:name><gtr:address><gtr:line1>Clatterbridge Road</gtr:line1><gtr:line2>Bebington</gtr:line2><gtr:postCode>CH63 4JY</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/337901E4-D9A7-438B-B275-0631F5F384A3"><gtr:id>337901E4-D9A7-438B-B275-0631F5F384A3</gtr:id><gtr:name>Royal Liverpool and Broadgreen University Hospital NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4B1932BB-05AF-4691-B8A1-0F150F1A3B53"><gtr:id>4B1932BB-05AF-4691-B8A1-0F150F1A3B53</gtr:id><gtr:name>Liverpool Heart and Chest Hospital</gtr:name><gtr:address><gtr:line1>Thomas Drive</gtr:line1><gtr:postCode>L14 3PE</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/32F58064-FBC3-4111-B6CF-201C3D0B5251"><gtr:id>32F58064-FBC3-4111-B6CF-201C3D0B5251</gtr:id><gtr:name>Astra Pharmaceuticals Canada</gtr:name><gtr:address><gtr:line1>35 Gatehouse Dr</gtr:line1><gtr:postCode>02451</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/62D8A395-B79B-4CD6-9803-7ADEA5C13F3F"><gtr:id>62D8A395-B79B-4CD6-9803-7ADEA5C13F3F</gtr:id><gtr:name>Bionow Ltd</gtr:name><gtr:address><gtr:line1>Manchester Science Park</gtr:line1><gtr:line2>Greenheys</gtr:line2><gtr:postCode>M15 6JJ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/37D62398-3B1B-477E-B041-9497CDF68D35"><gtr:id>37D62398-3B1B-477E-B041-9497CDF68D35</gtr:id><gtr:name>Liverpool Women's Hospital</gtr:name><gtr:address><gtr:line1>Neonatal Intensive Care Unit</gtr:line1><gtr:line2>Crown Street</gtr:line2><gtr:postCode>L8 7SS</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/07944F9A-421D-404B-BC16-79687AE5C68B"><gtr:id>07944F9A-421D-404B-BC16-79687AE5C68B</gtr:id><gtr:name>Liverpool Health Partners</gtr:name><gtr:address><gtr:line1>University of Liverpool</gtr:line1><gtr:line2>2nd Floor, Foundation Building</gtr:line2><gtr:line3>Brownlow Hill</gtr:line3><gtr:postCode>L69 7ZX</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/75E8E013-14E6-4087-9A77-106C53C2FC3F"><gtr:id>75E8E013-14E6-4087-9A77-106C53C2FC3F</gtr:id><gtr:name>Carl Zeiss SMT Ltd</gtr:name><gtr:address><gtr:line1>511 Coldhams Lane</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB1 3JS</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1D35766E-490B-41F1-BF31-76256F1E516B"><gtr:id>1D35766E-490B-41F1-BF31-76256F1E516B</gtr:id><gtr:name>North West Coast Academic Health Sci Nwk</gtr:name><gtr:address><gtr:line1>Room 505</gtr:line1><gtr:line2>Vanguard House</gtr:line2><gtr:line3>Sci-Tech Daresbury</gtr:line3><gtr:postCode>WA4 4AB</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/93EEC196-3499-4B58-AAEB-AF17754C67CF"><gtr:id>93EEC196-3499-4B58-AAEB-AF17754C67CF</gtr:id><gtr:name>Mirada Medical UK</gtr:name><gtr:address><gtr:line1>Oxford Centre for Innovation</gtr:line1><gtr:line2>New Road</gtr:line2><gtr:postCode>OX1 1BY</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4CFE310F-57E0-4B21-98F4-5848B9EFA709"><gtr:id>4CFE310F-57E0-4B21-98F4-5848B9EFA709</gtr:id><gtr:name>Walton Centre Neurology/Neurosurgery</gtr:name><gtr:address><gtr:line1>Walton Centre Neurology/Neurosurgery</gtr:line1><gtr:line2>Lower Lane</gtr:line2><gtr:line3>Fazakerley</gtr:line3><gtr:postCode>L9 7LJ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/ED6ACD61-0140-4C05-B93D-2C6A42CA753B"><gtr:id>ED6ACD61-0140-4C05-B93D-2C6A42CA753B</gtr:id><gtr:name>University of Salford</gtr:name><gtr:address><gtr:line1>University Crescent</gtr:line1><gtr:line4>Salford</gtr:line4><gtr:line5>Lancashire</gtr:line5><gtr:postCode>M5 4WT</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/32FA1809-8187-42E5-94B5-AF0749F0FA22"><gtr:id>32FA1809-8187-42E5-94B5-AF0749F0FA22</gtr:id><gtr:firstName>Ahmed</gtr:firstName><gtr:surname>Elsheikh</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/007D1EE0-41E5-48CB-95CE-046CF84106AB"><gtr:id>007D1EE0-41E5-48CB-95CE-046CF84106AB</gtr:id><gtr:firstName>Kieran</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Sharkey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6A21DE85-13F7-4621-AB7C-7BA787782C9C"><gtr:id>6A21DE85-13F7-4621-AB7C-7BA787782C9C</gtr:id><gtr:firstName>Marta Inmaculada</gtr:firstName><gtr:surname>Garcia-Finana (van der Hoek)</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/611BB300-3123-4C3C-B41C-2293649A1E4E"><gtr:id>611BB300-3123-4C3C-B41C-2293649A1E4E</gtr:id><gtr:firstName>Ruwanthi</gtr:firstName><gtr:surname>Kolamunnage-Dona</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E34AAE61-B48A-4183-84F9-9AA8802726C3"><gtr:id>E34AAE61-B48A-4183-84F9-9AA8802726C3</gtr:id><gtr:firstName>Violaine</gtr:firstName><gtr:surname>See</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/52F10D9F-DEED-41C2-95F1-CDAE77EC1F1F"><gtr:id>52F10D9F-DEED-41C2-95F1-CDAE77EC1F1F</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:surname>Movchan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8E3C1C3A-7814-4ABD-947F-4D91CAF129B9"><gtr:id>8E3C1C3A-7814-4ABD-947F-4D91CAF129B9</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Read</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/21174687-17E9-4779-A290-23C9BF49D594"><gtr:id>21174687-17E9-4779-A290-23C9BF49D594</gtr:id><gtr:firstName>Natasha</gtr:firstName><gtr:surname>Movchan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4CA0F340-519B-4D07-96FF-76F7CFA28F6F"><gtr:id>4CA0F340-519B-4D07-96FF-76F7CFA28F6F</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Weightman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D05B8EDC-C99E-4E7C-840D-241072B988D9"><gtr:id>D05B8EDC-C99E-4E7C-840D-241072B988D9</gtr:id><gtr:firstName>Rachel</gtr:firstName><gtr:otherNames>Naomi</gtr:otherNames><gtr:surname>Bearon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BBACFD33-79C8-4D2F-B2B5-FDA1659D7AC8"><gtr:id>BBACFD33-79C8-4D2F-B2B5-FDA1659D7AC8</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Barrett</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CF089CD8-E2A1-4566-A722-7E4C27726B76"><gtr:id>CF089CD8-E2A1-4566-A722-7E4C27726B76</gtr:id><gtr:firstName>Oleg</gtr:firstName><gtr:surname>Karpenkov</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/40790740-BB28-43A8-AA29-4882F1F26C4B"><gtr:id>40790740-BB28-43A8-AA29-4882F1F26C4B</gtr:id><gtr:firstName>K</gtr:firstName><gtr:surname>Chen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4D1C8043-40C7-4ADB-927E-B202A3FA4A66"><gtr:id>4D1C8043-40C7-4ADB-927E-B202A3FA4A66</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Horsburgh</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C5D38AFF-0D8F-4D11-B91B-7954A21AF259"><gtr:id>C5D38AFF-0D8F-4D11-B91B-7954A21AF259</gtr:id><gtr:firstName>Paula</gtr:firstName><gtr:surname>Williamson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3761F09B-F063-47C4-8C71-08DD65F82B08"><gtr:id>3761F09B-F063-47C4-8C71-08DD65F82B08</gtr:id><gtr:firstName>Anna</gtr:firstName><gtr:surname>Pratoussevitch</gtr:surname><gtr:orcidId>0000-0003-2248-6382</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DBA66509-BEC0-4B6E-8242-1C5C4DCEF35E"><gtr:id>DBA66509-BEC0-4B6E-8242-1C5C4DCEF35E</gtr:id><gtr:firstName>Francesco</gtr:firstName><gtr:surname>Falciani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2FF6EDF1-CDDB-4FBD-A232-C0E95FCFBA87"><gtr:id>2FF6EDF1-CDDB-4FBD-A232-C0E95FCFBA87</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>O Brien</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/219462CC-8152-4CD9-8202-3419410AC59B"><gtr:id>219462CC-8152-4CD9-8202-3419410AC59B</gtr:id><gtr:firstName>Gabriela</gtr:firstName><gtr:surname>Czanner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7EEE9654-4854-4AD1-ACEF-C87ACFACEC18"><gtr:id>7EEE9654-4854-4AD1-ACEF-C87ACFACEC18</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>D</gtr:otherNames><gtr:surname>Webb</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CD8ACC87-BB3C-49A7-BB92-E0D4A964D9C8"><gtr:id>CD8ACC87-BB3C-49A7-BB92-E0D4A964D9C8</gtr:id><gtr:firstName>Bakhtier</gtr:firstName><gtr:otherNames>Nasirovich</gtr:otherNames><gtr:surname>Vasiev</gtr:surname><gtr:orcidId>0000-0002-3452-7885</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FN014499%2F1"><gtr:id>9D7C8B16-C858-4606-81D3-C8702F5F939A</gtr:id><gtr:title>EPSRC Centre for New Mathematical Sciences Capabilities for Healthcare Technologies</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/N014499/1</gtr:grantReference><gtr:abstractText>As quality of life constantly improves, the average lifespan will continue to increase. Underlining this improvement is the vast amount of the UK government's support to NHS (&amp;pound;133.5 billion in year 2011/12) and the UK pharmaceutical industry's R&amp;amp;D large investment (4.9 billion to R&amp;amp;D in year 2011/12). The expectation of quality healthcare is inevitably high from all stakeholders. Fortunately recent advances in science and technology have enabled us to work towards personalised medicine and preventative care. This approach calls for a collective effort of researchers from a vast spectrum of specialised subjects. 
 Advances in science and engineering is often accompanied by major development of mathematical sciences, as the latter underpin all other sciences. The UoL Centre will consist of a large and multidisciplinary team of applied and pure mathematicians, and statisticians together with healthcare researchers, clinicians and industrialists, collaborating with 15 HEIs and 40 NHS trusts plus other industrial partners and including our strongest groups:
MRC Centre in Drug Safety Science, Centre for Cell imaging (CCI for live 3D and 4D imaging), Centre for Mathematical Imaging Techniques (unique in UK), Liverpool Biomedical EM unit, MRC Regenerative Medicine Hub, NIHR Health Protection Research Units, MRC Hub for Trials Methodology Research.
 Several research themes are highlighted below:
Firstly, an improved understanding of the interaction dynamics of cells and tissues is crucial to developing effective future cures for cancer. Much of the current work is in 2D, with restrictive assumptions and without access to real data for modelling. We shall use the unparalleled real data of cell interactions in a 3D setting, generated at UoL's CCI. The real-life images obtained will have low contrast and noise and they will be analysed and enhanced by our imaging team through developing accurate and high resolution imaging models. The main imaging tools needed are segmentaton methods (identifying objects such as cells and tissues regions in terms of sizes, shapes and precise boundaries). We shall propose and study a class of new 3D models, using our imaging data and analysis tools, to investigate and predict the spatial-temporal dynamics. 
 Secondly, better models of how drugs are delivered to cells in tissues will improve personalised predictions of drug toxicity. We shall combine novel-imaging data of drug penetration into 3D experimental model systems with multi-scale mathematical models which scale-up from the level of cells to these model systems, with the ultimate aim of making better in-vitro to in-vivo predictions. 
 Thirdly, there exist many competing models and software for imaging processing. However, for real images that have noise and are of low contrast, few methods are robust and accurate. To improve the modelling, applied and pure mathematicians team up to consider using more sophisticated tools of hyperbolic geometry and Riemann surfaces and fractional calculus to meet the demand for accuracy, and, applied mathematicians and statisticians will team up to design better data fidelity terms to model image discrepancies. 
 Fourthly, resistance to current antibiotics means that previously treatable diseases are becoming deadly again. To understand and mitigate this, a better understanding is needed for how this resistance builds up across the human interaction networks and how it depends on antibiotic prescribing practices. To understand these scenarios, the mathematics competition in heterogeneous environments needs to be better understood. Our team links mathematical experts in analysing dynamical systems with experts in antimicrobial resistance and GPs to determine strategies that will mitigate or slow the development of anti-microbial resistance. 
 Our research themes are aligned with, and will add value to, existing and current UoL and Research Council strategic investments, activities and future plans.</gtr:abstractText><gtr:potentialImpactText>Our team of applied, pure mathematicians and statisticians together with healthcare researchers, clinicians and industrialists will collaborate with 15 HEIs and 40 NHS trusts plus other industrial partners. Therefore the impact on the wide community is more pronounced and immediate than a responsive mode grant.

Academic impact. To the healthcare community, the proposed work will provide an insightful understanding of personalised medicine and preventative care. To the mathematical sciences community, the proposed work will advance several new directions in mathematics and statistics that will lead to high impact publications and high profile public addresses at major conferences. We see researchers in these communities as direct beneficiaries of the Centre.

The primary means of reaching out to users is by our User Engagement Forum via a series of Knowledge Exchange activities including visitor programmes; advisory service and maths and healthcare 'clinics'; summer schools; pump priming projects and activities to engage HEIs and industries; impact and public engagement activities; joint seminar series; workshops around specific problems. Some will be run with other EPSRC centres. 

Economic Impact. The UK pharmaceutical industry in 2007 contributed &amp;pound;8.4 billion to the UK's GDP, investing 4.3 billion to R&amp;amp;D which is the third-highest share of global pharmaceutical R&amp;amp;D. The NHS budget for the UK was &amp;pound;133.5 billion in 2011/12 and medicines account for 10% of the NHS budget i.e. &amp;pound;13.4 billion. The Centre will make major contributions to UK R&amp;amp;D:
(i). Aided by image technologies, understanding the progression of the disease process is important to enable the industry target relevant biological processes. (ii). Incorporation of protein/cell level dynamics into tissues is necessary and essential to predict the overall toxicity. This study will lead to treatments optimised for specific patients. The pharmaceutical industry interests in drugs with less side-effects and atified medicine. It will benefit from this Centre's new analysis tools and the UoL's MRC Centre in Drug Safety Science and MRC Regenerative Medicine Hub and Trials Hub in terms of extensive experimental data, computational simulations and scientific insights on tissues; therefore, we expect this impact to continue to be facilitated with our long-term collaborative partners and new parties to perform proof-of-principle trials.

Through existing and established connections, we would build further engagement including conversion of our results into commercial products. 

Societal Impact. Cancer is due to uncontrolled growth and spread of abnormal cells. Our proposed work, aiming for better understanding of cells and tissues, is crucial to combat cancer. There were 14M new sufferers (8M deaths) with 338K in UK alone in 2012. Research impact is of massive scale.

With aging, plaque due to cholesterol, calcium, and fibrous tissue can build up in arteries and due to such, they can narrow and stiffen. Coronary angioplasty and stenting are to improve blood flow in the body's arteries and veins, with 75,000 procedures performed in England per year. Our study will optimise designs to minimise side effects. It will be conducted with clinicians. Benefit and publicity to NHS are immediate. 

There is considerable concern in the society with common infectious diseases, which lead to 300M illnesses and more than 5M deaths each year worldwide with Ebola outbreak well-known and anti-microbial resistance posed as massive challenge. Finding a model for it by scaling up from small/local network information to large/global networks to understand diseases' network is of vital importance to Healthcare policy makers and service providers.

We will use these to engage the public at annual Science Festivals. We believe that these will not only raise awareness of the complexity in disease networks, but also generate interest in the community fascinated by bio-mimic system.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2015-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2004298</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Public Health England</gtr:description><gtr:id>446E4AAC-23A9-4A21-81B2-708E43447E62</gtr:id><gtr:impact>Paper submitted: &amp;quot;Using propensity score estimation in an adjusted study design for estimating indirect and direct vaccine effectiveness in observation studies, with application to rotavirus vaccination&amp;quot;. Multi-disciplinary (epidemiology, mathematics, socio-demographic modelling, medicine).</gtr:impact><gtr:partnerContribution>Provided time for meetings</gtr:partnerContribution><gtr:piContribution>Scoping work to identify research questions of direct relevance to PHE regarding influenza evolution and transmission within the UK.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Infectious Disease Modelling Summer School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1C8DE106-3558-47F7-9AAB-61185BC8F0B2</gtr:id><gtr:impact>Two week-long workshop held in Japan for public health practitioners and graduate students to develop a practical understanding of infectious disease modelling. Read was delivered sessions on seasonal influenza epidemiology and modelling epidemics in structured populations. Audience was drawn from Japan as well as other countries in the region (including South Korea, China, Indonesia, Philippines).</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://sites.google.com/site/modelinfection/home/shortcourse3</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop 4 (T3)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D2171563-1DFF-470E-97A1-5EFFF3F008A8</gtr:id><gtr:impact>A workshop is being planned for summer 2017 to engage with policy makers and other stakeholders.
The subject of AMR modeling and influenza modeling is a major healthcare topic that is studied at the Liverpool Centre.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.tinyurl.com/EPSRC-LCMH</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>workshop 3 (Imaging) jointly with Cambridge CMIH Centre</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F973A1FA-169F-4BAC-83F4-2870D694880A</gtr:id><gtr:impact>This is a joint event with and held in Cambridge.
The teams from all 5 UK centres will be represented, excellent example of UK coherent research efforts in tackling imaging problems.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.turing-gateway.cam.ac.uk/event/tgmw42</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centre workshop 1 - Sept 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2657CC6-0982-4080-A4E6-BFFA01538DDE</gtr:id><gtr:impact>Imaging workshop where we reported our projects and findings, invited industrial partners to tell us their challenges in their work.
The networking event is well received.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.tinyurl.com/EPSRC-LCMH</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centre workshop 2</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6E4AB65B-5A32-4BCC-9064-F7DD8B74AF05</gtr:id><gtr:impact>Stenting for abdominal aortic aneurysms - modeling experts met clinicians and industrial partners and new / potential collaborators.
New results are highlighted and new problems are identified.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.tinyurl.com/EPSRC-LCMH</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>86000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC - iCASE studentship (Smith Institute)</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EPSRC Voucher 17000203</gtr:fundingRef><gtr:id>DA7C7F16-51BC-498A-A8D1-359416D5807A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>168000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Engineering and Physical Sciences Research Council EPSRC</gtr:department><gtr:description>EPSRC First Grant Scheme (Dr T Valkonen) Centre New lecturer</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:fundingRef>EP/P021298/1</gtr:fundingRef><gtr:id>97C2FC77-DE39-46E1-837D-24F96452B0B3</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The Centre grant aims to tackle healthcare challenges proposed by clinicians and industrialists by novel mathematics.
Thus each started project (two so far) has aimed for direct impact to healthcare sector, specifically 
(1) the Stenting project (Theme 1 Project 1) has produced initial results that can be used by clinicians to facilitate selection of stents
 towards personalization.
(2) the Interactive Segmentation project (Theme 2 Project 1) has also produced impressive results (as with directly industrial involvement)
 and the collaborating partner will start formal validation process this year to aim for adoption into products. 
 Our work will potentially impact future NHS diagnostic tools and platforms from which we take pride.
(3) the influenza project (Theme 3 Project 1) is developing National scale population models of influenza sub-type transmission, infection and immunity. 
 World Health Organization data will be used to infer key parameter values pertaining to antigenic drift rates and subtype transmission and interactions. 
 A workshop is being planned for summer 2017 to engage with policy makers and other stakeholders.</gtr:description><gtr:firstYearOfImpact>2017</gtr:firstYearOfImpact><gtr:id>A75F8017-5206-45F4-B7CD-09034C691211</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Digital/Communication/Information Technologies (including Software),Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The project only started 8 months ago (though the programme starting was 1 year ago, due to arrpoval given 1 week before starting date).

1. T1 Project 1 (stenting). We have a relationship between stents' size and damage to the stents in operating conditions. This is through
 constructive description of favourable and unfavourable conditions for endovascular sealing of abdominal aortic aneurysms.

2. T2 Project 1 (segmentation using partial priors). We have designed reliable minimal path-following algorithms to produce an accurate segmentation
 which is much faster than the usual fully 3D models. The speed-up is from dimension reduction while the reliability is by achieving non-intersecting paths.</gtr:description><gtr:exploitationPathways>Through our projects partners. They participate the projects directly.</gtr:exploitationPathways><gtr:id>B3007FD9-2FB1-4882-BF08-954FDAEE5C38</gtr:id><gtr:sectors><gtr:sector>Communities and Social Services/Policy,Digital/Communication/Information Technologies (including Software),Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/106BCFD4-6E03-4D1D-8B5C-D93F525BAC29"><gtr:id>106BCFD4-6E03-4D1D-8B5C-D93F525BAC29</gtr:id><gtr:title>Wave reflection and transmission in multiply stented blood vessel</gtr:title><gtr:parentPublicationTitle>Proceedings of the Royal Society, London, Ser A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3eef01c78f7805c4fdc03120837373f5"><gtr:id>3eef01c78f7805c4fdc03120837373f5</gtr:id><gtr:otherNames>T. Papathanasiou</gtr:otherNames></gtr:author></gtr:authors></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/98DBBC7B-AEFA-48D9-9BBE-F8F76C567D65"><gtr:id>98DBBC7B-AEFA-48D9-9BBE-F8F76C567D65</gtr:id><gtr:title>Deformation and dynamic response of abdominal aortic aneurysm sealing</gtr:title><gtr:parentPublicationTitle>Nature Scientific Reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/683e04d7c13d3c9e0c2b68b61758e03a"><gtr:id>683e04d7c13d3c9e0c2b68b61758e03a</gtr:id><gtr:otherNames>Luca Argani</gtr:otherNames></gtr:author></gtr:authors></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/N014499/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>AEB7EC61-1574-4583-8B00-BD32275F29A6</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Complexity Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>DEA11FBC-BEED-4EDD-890B-97D728462D26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Mathematical sciences</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>AEB7EC61-1574-4583-8B00-BD32275F29A6</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Complexity Science</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>16595C3C-600D-4AD2-B394-16E06F96495F</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Med.Instrument.Device&amp; Equip.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>15</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>93E27C3B-6D00-4F18-BBE3-96C05C8F92B2</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Non-linear Systems Mathematics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>CFBD6626-50CB-4AA6-8B49-9A76519BA91F</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Numerical Analysis</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>